🔎 Trials Near Me

Hjem › Skleroderma › South Carolina

Kliniske studier for Skleroderma i South Carolina

4 studier for Skleroderma søker deltakere på steder i South Carolina.

Byer i South Carolina

Offisiell studietekst (engelsk)

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

  • Medical University of South Carolina, Charleston
  • Prisma Health, Greenville
RekruttererFase 1
Alder 18 til 74 · Alle kjønn · Oppdatert 10. sep. 2026 · NCT07085104

Platform Clinical Study for Conquering Scleroderma

  • Medical University of South Carolina (MUSC), Charleston
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT06195072

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

  • Artiva Investigational Site Charleston, Charleston
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 31. jul. 2026 · NCT06991114

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

  • aTyr Investigative Site, Charleston
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 7. mai 2025 · NCT05892614

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.